SUZHOU KINTOR PHARMACEUTICALS
Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more than 50% of the global cancer population and lack of effective treatment method. They have a product pipeline built on proprietary R&D and licensing arrangement, aiming to provide the best treatment plans for huge unmet patient needs. They focus on developing a full R&D and commercialization platform for “best-in-class” and “first-in-class” novel drugs.
SUZHOU KINTOR PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Health Care Life Science Pharmaceutical
Founded:
2009-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.kintor.com.cn
Total Employee:
251+
Status:
Active
Contact:
+86-512-62956307
Email Addresses:
[email protected]
Total Funding:
99 M USD
Technology used in webpage:
SPF Domain Not Resolving Euro Amazon DNSSEC DMARC Microsoft Azure DNS Amazon Route 53 Amazon CloudFront CrUX Top 5m
Similar Organizations
Coherent Biopharma
Coherent Biopharma is a pahrmaceutical based agency.
Curon Biopharma
Curon Biopharma is a Healthcare company.
eSense-Lab
eSense-Lab is an Israel-based pharmaceutical technology company
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
HuniLife Biotechnology
HuniLife Biotechnology is a paramedical research center.
Northwest Clinical Trials
Northwest Clinical Trials is a medical research clinic.
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
Pharmoptima
Pharmoptima provides drug discovery and pharmaceutical research services.
Zhongke Jiankang Wang
Zhongke Health Industry Group is a pharmaceutical manufacturing company.
Current Employees Featured
Founder
Investors List
CCB International
CCB International investment in Series D - Suzhou Kintor Pharmaceuticals
FTZ Fund
FTZ Fund investment in Series D - Suzhou Kintor Pharmaceuticals
Highlight Capital
Highlight Capital investment in Series D - Suzhou Kintor Pharmaceuticals
Huajin Capital
Huajin Capital investment in Series D - Suzhou Kintor Pharmaceuticals
Oriza Holdings
Oriza Holdings investment in Series C - Suzhou Kintor Pharmaceuticals
Green Pine Capital Partners
Green Pine Capital Partners investment in Series C - Suzhou Kintor Pharmaceuticals
Broad Resources
Broad Resources investment in Series C - Suzhou Kintor Pharmaceuticals
China Orient Asset Management (International) Holding
China Orient Asset Management (International) Holding investment in Series C - Suzhou Kintor Pharmaceuticals
CCB International
CCB International investment in Series C - Suzhou Kintor Pharmaceuticals
Highlight Capital
Highlight Capital investment in Series C - Suzhou Kintor Pharmaceuticals
Official Site Inspections
http://www.kintor.com.cn Semrush global rank: 2.33 M Semrush visits lastest month: 8.64 K
- Host name: 120.133.2.80
- IP address: 120.133.2.80
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai
More informations about "Suzhou Kintor Pharmaceuticals"
Corporate Governance-Kintor Pharmaceutical Limited
Kintor Pharmaceutical Limited Corporate Governance Focusing on the development and industrialization of potential "best-in-class" and "first-in-class" innovative drugs.See details»
Company Profile-Kintor Pharmaceutical Limited
About Kintor Pharma. Founded in 2009, Kintor Pharma focuses on developing innovative small molecules and biologic drugs for dermatology and oncology with substantial unmet needs, especially androgen receptor-related diseases. ...See details»
公司介绍-Kintor Pharmaceutical Limited
首页. 关于我们. 公司介绍. 管理团队. 发展历程. 公司荣誉. 药物. 在研药物. 研发平台. 商务拓展. 化妆品. 国内销售. 海外销售See details»
Kintor Pharmaceutical Limited-小分子创新药-生物创新药
开拓药业成立于2009年，专注发展潜在“best-in-class”和“first-in-class”创新药物的研发及产业化，致力成为创新疗法研究、开发及商业化的领军企业。See details»
Suzhou Kintor Pharmaceuticals - Crunchbase
Contact Email [email protected]; Phone Number +86-512-62956307; Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more …See details»
在研药物-Kintor Pharmaceutical Limited
关于我们. 公司介绍. 管理团队. 发展历程. 公司荣誉. 药物. 在研药物. 研发平台. 商务拓展. 化妆品. 国内销售. 海外销售. 化妆 ...See details»
Kintor Pharmaceutical Limited - LinkedIn
Kintor Pharmaceutical Limited is developing and commercializing a robust pipeline of innovative small molecule and biological therapeutics for androgen-receptor and tumor-related disease areas ...See details»
Management Team-Kintor Pharmaceutical Limited
Over 25 years of experience in clinical development, pharmacovigilance and clinical quality management Served in AstraZeneca and other world's leading international pharmaceutical giants， as well as in and several innovative …See details»
Suzhou Kintor Pharmaceuticals, Inc.
了解Suzhou Kintor Pharmaceuticals, Inc. (苏州开拓药业股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的31项临床试验, 27篇新闻和9篇文献，疾病领域:肿瘤，血液及淋巴系统 …See details»
Kintor Company Profile - Office Locations, Competitors, Revenue
Kintor is a company that discovers cancer treatment solutions. The company focuses on developing drugs for three major cancer fields: prostate cancer, breast cancer, and liver …See details»
Kintor CEO and Key Executive Team | Craft.co
Kintor's Founder, Chairman, CEO is Youzhi Tong. Other executives include Xunwei Dong, CMO; Lucy Lu, CFO and 5 others. See the full leadership team at Craft. ... Source: en.kintor.com.cn. …See details»
Kintor Pharmaceutical - Overview, News & Similar companies
Oct 11, 2023 Kintor Pharmaceutical Limited is developing and commercializing a robust pipeline of innovative small molecule and biological therapeutics for andr ogen-receptor and tumor …See details»
Kintor Pharmaceutical Limited - kintor.com.cn
网站名称-主营业务介绍开拓药业成立于2009年，专注发展潜在“best-in-class”和“first-in-class”创新药物的研发及产业化，致力成为创新疗法研究、开发及商业化的领军企业。See details»
Suzhou Kintor Pharmaceuticals, Inc. - Drug pipelines, Patents
The drug GT20029 is being developed by Suzhou Kintor Pharmaceuticals, Inc., an originator organization based in China. It has reached the phase 2 of clinical development. Phase 2 trials …See details»
Kintor 2025 Company Profile: Stock Performance & Earnings
Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China focused on the proprietary R&D of drugs for cancers and other AR-related diseases. The company's drug candidate, Pruxelutamide, is a drug undergoing phase III clinical trials in China and phase III clinical trials in the United States for mCRPC as well as clinical trials for breast cancer.See details»
苏州开拓药业股份有限公司_www.kintor.com.cn
Dec 22, 2024 苏州开拓药业股份有限公司：开拓药业成立于2009年，专注发展潜在“best-in-class”和“first-in-class”创新药物的研发及产业化，致力成为创新疗法研究、开发及商业化的领 …See details»
Kintor Pharmaceutical Limited-Bio-innovative medicine
Hello, welcome to the official website! Contact Phone:400-000-0000 All. All; Product Management; News; Introduction; Enterprise outletsSee details»
发展历程-Kintor Pharmaceutical Limited
Kintor Pharmaceutical Limited 发展历程 开拓药业成立于2009年，专注发展潜在“best-in-class”和“first-in-class”创新药物的研发及产业化，致力成为创新疗法研究、开发及商业化的领军企业。See details»
research and development-Kintor Pharmaceutical Limited
Research and development: The research and development teams in Suzhou, Shanghai and the United States work closely to form a globally integrated R&D platform and carry out the …See details»
Announcements and circulars-Kintor Pharmaceutical Limited
Kintor Pharmaceutical Limited Announcements and circulars Focusing on the development and industrialization of potential "best-in-class" and "first-in-class" innovative drugs.See details»